Why Do Some Patients' Cells Work and Others Don't?

The biggest unsolved problem in cell therapy is donor variability. Why one patient's cells work and another's fail is a question the field still cannot answer. Alex Ward and Caelan Anderson, co-founders of Tolemy Bio, are building the intelligence layer that cell therapy has been missing. Their platform Orbit integrates all the process context around how cells are grown, managed, and manufactured to surface insights that nobody is currently leveraging. The goal is adaptive, patient-specific manufacturing across seventeen dimensions. Alex Ward and Caelan Anderson are co-founders of Tolemy Bio, a company building an AI-powered control panel for cell therapy manufacturing. Chapters 00:00:00 Welcome: Alex Ward + Caelan Anderson, Tolemy Bio 00:00:46 What Is Tolemy Bio and What Are They Building? 00:04:25 Why Do Some Patients' Cells Fail and Others Don't? 00:05:46 The Data Problem in Cell Therapy 00:14:00 The Control Panel for the Cell 00:15:15 Why Tolemy's Models Are Not Black Boxes 00:20:30 Adaptive Manufacturing Is the Future 00:25:34 What's Next in Biotech New episodes every Tuesday and Thursday at 11:00 AM 🚀